» Articles » PMID: 10430231

Geographic Variation in Sarcoidosis in South Carolina: Its Relation to Socioeconomic Status and Health Care Indicators

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 1999 Aug 3
PMID 10430231
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Geographic patterns of sarcoidosis have been detected and studied on a global scale. However, the associations between these disease patterns and population characteristics have not been determined. The authors studied the geographic pattern of sarcoidosis in South Carolina and its relation to socioeconomic status (SES) and health status indicators. Hospitalization rates for the period 1985-1995 were used as geographic indicators of sarcoidosis. Rates were assessed for the 46 counties in South Carolina, adjusting for differences in SES, availability/accessibility of health care, diagnostic practices, and hospital utilization. Patterns in geographic variation were assessed based on physiographic characteristics and proximity to the Atlantic coastline. Significant variation was identified with an increase in sarcoidosis rates proximal to the Atlantic coastline. Population characteristics were identified that appeared to explain regional variation in sarcoidosis in Caucasians; however, regression analysis was unable to explain the regional differences in disease distribution by variation in SES, diagnostic practices, accessibility/availability, or hospital utilization in African Americans. These results suggest that the development of sarcoidosis is associated with a geographically linked risk factor in African Americans. This work supports the need for additional studies that will identify this risk factor(s).

Citing Articles

Identifying sarcoidosis trends using web search and real-world data in Sweden: a retrospective longitudinal study.

Ziehfreund S, Tizek L, Arkema E, Zink A Sci Rep. 2024; 14(1):19260.

PMID: 39164281 PMC: 11335935. DOI: 10.1038/s41598-024-69223-8.


Design and rationale of a pilot randomized clinical trial investigating the use of a mHealth app for sarcoidosis-associated fatigue.

Chandler J, Christon L, Benfield K, Pairet S, Hoffman M, Treiber F Contemp Clin Trials Commun. 2023; 32:101062.

PMID: 36718177 PMC: 9883180. DOI: 10.1016/j.conctc.2023.101062.


Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review.

Gilotra N, Griffin J, Pavlovic N, Houston B, Chasler J, Goetz C J Card Fail. 2021; 28(1):113-132.

PMID: 34260889 PMC: 8748280. DOI: 10.1016/j.cardfail.2021.06.016.


A Primer on the Clinical Aspects of Sarcoidosis for the Basic and Translational Scientist.

Judson M J Clin Med. 2021; 10(13).

PMID: 34203188 PMC: 8268437. DOI: 10.3390/jcm10132857.


Environmental Risk Factors for Sarcoidosis.

Judson M Front Immunol. 2020; 11:1340.

PMID: 32676081 PMC: 7333358. DOI: 10.3389/fimmu.2020.01340.